Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP805091.RAVGTi4g5gTZtuQ8uCXxBzPftOyVh62dn5OcY8a-ORjeI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP805091.RAVGTi4g5gTZtuQ8uCXxBzPftOyVh62dn5OcY8a-ORjeI130_assertion type Assertion NP805091.RAVGTi4g5gTZtuQ8uCXxBzPftOyVh62dn5OcY8a-ORjeI130_head.
- NP805091.RAVGTi4g5gTZtuQ8uCXxBzPftOyVh62dn5OcY8a-ORjeI130_assertion description "[Methotrexate and 6-mercaptopurine, important components of acute lymphoblastic leukemia treatment, are substrates for multidrug resistance-associated protein MRP4.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP805091.RAVGTi4g5gTZtuQ8uCXxBzPftOyVh62dn5OcY8a-ORjeI130_provenance.
- NP805091.RAVGTi4g5gTZtuQ8uCXxBzPftOyVh62dn5OcY8a-ORjeI130_assertion evidence source_evidence_literature NP805091.RAVGTi4g5gTZtuQ8uCXxBzPftOyVh62dn5OcY8a-ORjeI130_provenance.
- NP805091.RAVGTi4g5gTZtuQ8uCXxBzPftOyVh62dn5OcY8a-ORjeI130_assertion SIO_000772 19515727 NP805091.RAVGTi4g5gTZtuQ8uCXxBzPftOyVh62dn5OcY8a-ORjeI130_provenance.
- NP805091.RAVGTi4g5gTZtuQ8uCXxBzPftOyVh62dn5OcY8a-ORjeI130_assertion wasDerivedFrom befree-20140225 NP805091.RAVGTi4g5gTZtuQ8uCXxBzPftOyVh62dn5OcY8a-ORjeI130_provenance.
- NP805091.RAVGTi4g5gTZtuQ8uCXxBzPftOyVh62dn5OcY8a-ORjeI130_assertion wasGeneratedBy ECO_0000203 NP805091.RAVGTi4g5gTZtuQ8uCXxBzPftOyVh62dn5OcY8a-ORjeI130_provenance.